Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
about
From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive DisorderQuinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.Impaired inhibitory control is associated with higher-order repetitive behaviors in autism spectrum disordersManagement of obsessive-compulsive disorder with fluvoxamine extended releaseDopaminergic control of cognitive flexibility in humans and animalsRole of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.Positron emission tomography in psychiatric disorders.Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.The application of deep brain stimulation in the treatment of psychiatric disorders.Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment.Approach and avoidance learning in obsessive-compulsive disorder.Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.Plasma fluvoxamine levels and OCD symptoms/response in adult patientsCatechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder
P2860
Q26774751-7C7FBAE5-93A1-4F54-B02C-A66DBFFFB769Q33310422-B3423B05-DBE8-4201-B9D9-9E5989DCF6C8Q35133206-8CEFCB90-B640-499A-8FEF-B5A5D7D4CC35Q37235709-BDF0B8F3-C031-43CD-B1A1-9194A723C57BQ37279397-3E16A688-980E-4AD7-8425-937E743D1EF0Q37688083-EED2CC98-BA8B-452E-B8FA-2BBB615905F5Q37975237-6A51898C-15A0-4FE0-9BC9-0AAAE31D36CBQ38212792-D4F5CFD7-24ED-41D1-8549-1712A32563C7Q38681849-B16E53ED-26F6-4C67-820B-33F53DE7E2B6Q42057773-DAFCA69B-D9B4-467B-8D9B-227A9F8BBFAEQ48016660-51BB3D17-4C41-4F77-B1A3-E24EF30D2E82Q48156228-6A7A202D-3D39-46D8-8B53-5A5C002A9EB4Q55163173-F2B3CA8E-B0CE-4A56-9C47-BEDC8D7431B3Q57730496-AFD0481C-7566-4974-AC5D-324CCC74FF57Q58887973-4C3F6C0F-B89B-4630-BB1E-D6F44489F1F3
P2860
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
@en
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
@nl
type
label
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
@en
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
@nl
prefLabel
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
@en
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
@nl
P2093
P2860
P356
P1476
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.
@en
P2093
Andrea Panzacchi
Assunta Carpinelli
Clara Gobbo
Daniela Perani
Ferruccio Fazio
Laura Bellodi
Lorena Bonaldi
Lucia Pietra
Marco Locatelli
Marta Henin
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301199
P407
P577
2006-10-04T00:00:00Z